- affects 1 in every 120-300 North Americans2...1 in 100-200 in USA11!
Yet about a third of the population is constitutionally genetically positioned to have it.
- serological & genetic screening tests:
But, serology only has a chance to detect gluten sensitive enteropathy
(GSE...celiac disease [CD])...a type of protein sensitive enteropathy (PSE)...protein intolerance enteropathy (PIE)...and
will not detect other types of PIEs or PSEs (soy, tuna, chicken, etc.). And 3% of celiac cases are IgA deficient11. Serology
plus biopsy: therefore, our gastroenterologists tend to work
up possible PIE (especially looking for CD) with serology plus EGD with distal duodenal biopsy
(and we carefully analyze biopsy morphology and the presence
and character of intra-epithelial T lymphocytes [with IHC stain
for CD3] in search of increased IELs).
- Morphologically diagnostic: Presence of abnormal biopsy (increased IELs as seen by CD3-amplified histology) when
patient on ordinary diet, and improvement in histologic features
when on a gluten-free diet.
- Clinically diagnostic: usually steadily consistent5 set
of symptoms of chronic disease (whereas IBS tends to be intermittent)
which improves on a strict gluten free diet. Refractory sprue
most commonly is due to diet never getting completely gluten
free; and, since proximal mucosa is the last to become normal
after gluten elimination, refractoriness with a normal biopsy
suggests comorbidities such as lactase deficiency, pancreatic
insufficiency, IBD, bacterial overgrowth, collagenous or lymphocytic
colitis, etc...still abnormal biopsy might be GSE or T-cell lymphoma6.
- Biopsy location affects histology & EGD biopsies preferred:
- Proximal has most prominent findings; terminal ileum has minimal
change (therefore, biopsy distal duodenum endoscopically).
- Crest of mucosal fold has greater change than intervening troughs.
- Is celiac "ruled out"? Maybe it is a GSE family member, &
the screening serology was negative & they are currently medically normal. If correctly
performed genetic testing [check here] is negative for the
constitutional genotype making GSE possible, then GSE is probably ruled out in that patient.
And, on the other hand, constitutional lack of the proper genetic setting probably rules it
out in people with GSE "disease-compatible" signs & symptoms.
[August 2009 memo to one of our FPs].
- Clinical Presentations of GSE 3:
- iron-deficiency anemia (about
3% of cases9...10-15%11)
- osteoporosis (4.5% of cases)8
- diarrhea (45-85% of cases)11
- fatigue (75-80% of cases)11
- borborygmus (35-72% of cases)11
- weight loss (45% of cases)11
- bloating/abdominal distension (33% of cases)11
- flatulence (28% of cases)11
- 10% have elevated SGPT (ALT)
- lactose intolerance
- pregnant women have a 9-fold
increased rate of spontaneous abortion4
- failure to thrive (and IUGR4)
- abdominal distension
- less common:
- short stature
- delayed puberty
- neurologic dysfunction (such as cerebellar ataxia11)
- nausea and/or vomiting
- recurrent mouth ulcers (aphthous
- recurrent abdominal pain
- abnormal serum liver function
- folate-deficiency anemia
- vitamin K deficiency (PT prolonged)
- thrombocytosis (hyposplenism)
- arthralgia, arthropathy
- unexplained delayed puberty
- peripheral neuropathy
- dental enamel defects
- dermatitis herpetiformis
- associated clinical conditions: relatives with celiac disease, irritable bowel syndrome (IBS), Sjogren's syndrome, autoimmune hepatitis, primary biliary cirrhosis, premature onset of osteoporosis, autoimmune thyroid disorders; Down syndrome; Turner syndrome; type I diabetes mellitus11.
- potential complications or presenting
complications: small bowel lymphoma...non-Hodgkin lymphoma is 3-6x more common in celiac cases and oropharyngeal, esophageal, and small intestinal carcinomas are more prevelant in celiac cases11.
- Histologic Features:
- Villous length vs. crypt depth: Normal
is > 3:1 & GSE has lower ratios later in the disease.
- Apoptotic cells
- Reactive nuclei
IELs (intra-epithelial lymphs...> 1
lymph/ 5 epithelials...lymphs are T-cells...by H&E [we found that IHC amplification will find apparently normal...not GSE...IELs by VTS within a range of 1-8 per 20 villus tip epithelials...I report about 8-11 as borderline and higher as abnormal).
- Loss of nuclear polarity...pseudo-stratified
- Loss of brush boarder
- Cytoplasmic vacuolization
- Goblet cells increased in number
- Crypt hyperplasia later in the disease
- Increased mitoses
- Endocrine cell hyperplasia (chromogranin
- Pyloric metaplasia later in the disease (or is THAT due to hyperacidity?)
- Lamina Propria:
- Increased B-lymphs & plasma cells
- May have increased eos & mast cells
- Adipose metaplasia
- Plasma cells go from IgA to IgG & M
- Increased nerve fibers
- Two Forms:
- Flat mucosa with villous blunting
- Relatively normal architecture, with increased IELs. This
change is said to be present in 33% of relatives of patients with GSE.
- Conditions which may mimic GSE histologically:
- infectious gastroenteritis
- tropical sprue
- tuna, cow milk, soy bean, and other protein intolerance
- common variable hypogammaglobulinemia
- AIDS enteropathy
- Crohn’s disease
- eosinophilic gastroenteritis
- dermatitis herpetiformis
- viral enteritis
- auto-immune enteritis
- drug effects (?)......................[back
to enteritides (more detail)]
- Fenoglio-Preiser textbook
(primary ref. source)
- NEJM 17 Jan. 2002 346:180-187.
- Loftus CG, Murray JA, (Division of Gastroenterology & Hepatology,
Mayo Clinic, Rochester) Celiac Disease: Diagnosis and Management,
JCOM 9(6):341-349 June 2002.
- Goldstein, NS and Underhill, J, Morphologic Features Suggestive
of Gluten Sensitivity in Architecturally Normal Duodenal Biopsy
Specimens, AJCP 116(1):63-71, July 2001.
- Schade RR, Prof. & Chief GI @ MCG, Augusta, Ga., Letter
to Ed., Medical Crossfire 5(3):19, April 2003.
- Petras RE, A Practical Approach to Gastrointestinal pathology:
Small Bowel Biopsy Interpretation and Specimen Handling, US & Canadian
Academy of Pathology, March 2002 (91st annual meeting) short
course handout, 10 pages (online @ USCAP website).
- Settakorn J, et. al., "Imunohistologic Parameters...",
Applied Immunohistochemistry & Molecular Morphology, 12(3):198-204,
- Barclay L, online Medscape Medical News, 2/28/05, All Patients
With Celiac Disease May Benefit From Screening for Celiac Disease.
- South Med J. 2004;97:30-34...noted
in online Medscape Medical News, 2/12/04.
- Carter JB, NewsPath, March 2008 (celiac serology review).
- Presutti RJ, et. al., "Celiac Disease", American Family Physician 76(12):1795-1802, 15 Dec. 2007.
- see how primary care doc may be working a case up at Family Practice Notebook.
- our lab update memo of 8/31/2009 HERE.
2/9/02; latest addition 2 January 2013)